Risk factors and antiplatelet therapy in TIA and stroke patients

Journal of the Neurological Sciences

Volumn 154, Issue 2, 1998, Pages 200-204

  Puranen, Juha ^a   Laakso, Markku ^a   Riekkinen Sr , Paavo ^a   Sivenius, Juhani ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antiplatelet treatment; Risk factors; Stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; PLACEBO;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; CEREBROVASCULAR DISORDERS; DIPYRIDAMOLE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FINLAND; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0032485012     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00229-3     Document Type: Article

References (34)

1. Abbott R.D., Yin Y., Reed D.M., Yano K. Risk of stroke in male cigarette smokers. New Engl. J. Med. 315:1986;717-720.
2. Abbott R.D., Donahue R.P., MacMahon S.W., Reed D.M. Diabetes and the risk of stroke. The Honolulu heart program. J. Am. Med. Assoc. 251:1987;949-952.
3. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 308:1994;81-106.
4. Baudoin C., Bousser M.-G., Haguenau M., Lefauconnier J.-M., Eschwege E. Secondary prevention of strokes: Role of platelet antiaggregant drugs in diabetic and non-diabetic patients. Diabetic Med. 2:1985;145-146.
5. Bornstein N.M., Karepov V.G., Aronovich B.D., Gorbulev A.Y., Treves T.A., Korczyn A.D. Failure of aspirin treatment after stroke. Stroke. 25:1994;275-277.
6. Caplan L.R., Gorelick P.B., Hier D.B. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 17:1986;648-655.
7. Chyatte D., Chen T.L. Patterns of failure of aspirin treatment in symptomatic atherosclerotic carotid artery disease. Neurosurgery. 26:1990;565-569.
8. Colditz G.A., Bonita R., Stampfer M.J., Willett W.C., Rosner B., Speizer F.E., Hennekens C.H. Cigarette smoking and risk of stroke in middle-aged women. New Engl. J. Med. 318:1988;937-941.
9. Collins R., Peto R., MacMahon S., Herbert P., Fiebach N.H., Eberlein K.A., Godwin J., Qizilbash N., Taylor J.O., Hennekens C.H. Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 335:1990;827-838.
10. Davis P.H., Dambrosia J.M., Schoenberg B.S., Schoenberg D.G., Pritchard D.A., Lilienfeld A.M., Whisnant J.P. Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Ann. Neurol. 22:1987;319-327.
11. Dennis M.S., Bamford J.M., Sandercock P.A., Warlow C.P. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke. 20:1989;333-339.
12. Dennis M.S., Bamford J.M., Sandercock P.A., Warlow C.P. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke. 20:1989;1494-1499.
13. Donnan G.A., McNeil J.J., Adena M.A., Doyle A.E., O'Malley H.M., Neill G.C. Smoking as a risk factor for cerebral ischaemia. Lancet. ii:1989;643-647.
14. ESPS Group European stroke prevention study. Stroke. 21:1990;1122-1130.
15. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br. Med. J. 287:1983;867-870.
16. Haberman S., Capildeo R., Rose F.C. Sex differences in the incidence of cerebrovascular disease. J. Epidemiol. Community Health. 35:1981;45-50.
17. Hankey G.J., Slattery J.M., Warlow C.P. The prognosis of hospital-referred transient ischaemic attacks. J. Neurol. Neurosurg. Psychiatry. 54:1991;793-802.
18. Hypertension Detection and Follow-up Program Cooperative Group Five-year findings of the Hypertension Detection and Follow-up Program: III. Reduction in stroke incidence among persons with high blood pressure. J. Am. Med. Assoc. 247:1982;633-638.
19. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease: The Framingham Study. J. Am. Med. Assoc. 241:1979;2035-2038.
20. Kannel, W.B., Wolf, P.A., 1983. Epidemiology of cerebrovascular disease. In: Ross-Russell, R.W. (Ed.), Vascular Disease of the Central Nervous System, 2nd ed. Churchill Livingstone, Edinburgh, pp. 1-24.
21. Kannel W.B., Dawber T.R., Sorlie P., Wolf P.A. Components of blood pressure and risk of atherothrombotic brain infarction: The Framingham Study. Stroke. 7:1976;327-331.
22. Kannel W.B., Wolf P.A., McGee D.L., Dawber T.R., McNamara P., Castelli W.P. Systolic blood pressure, arterial rigidity, and risk of stroke: The Framingham Study. J. Am. Med. Assoc. 245:1981;1225-1229.
23. Kuusisto J., Mykkänen L., Pyörälä K., Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 25:1994;1157-1164.
24. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease: part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 335:1990;765-774.
25. Passero S., Rossi G., Nardini M., Bonelli G., D'Ettorre M., Martini A., Battistini N., Albanese V., Bono G., Brambilla G.L., Candelise L., De Zanche L., Inzitari D., Rasura M., Fieschi C. Italian multicenter study of reversible cerebral ischemic attacks. Part 5. Risk factors and cerebral atherosclerosis. Atherosclerosis. 63:1987;211-224.
26. Sacco R.L., Foulkes M.A., Mohr J.P., Wolf P.A., Hier D.P., Price T.R. Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke. 20:1989;983-989.
27. Shinton R., Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br. Med. J. 298:1989;789-794.
28. Sivenius J., Heinonen O.P., Pyörälä K., Salonen J., Riekkinen P. The incidence of stroke in the Kuopio area of East Finland. Stroke. 16:1985;188-192.
29. Sivenius J., Riekkinen P.J.S., Smets P., Laakso M., Lowenthal A. The European Stroke Prevention Study (ESPS): results by arterial distribution. Ann. Neurol. 29:1991;596-600.
30. Sivenius J., Laakso M., Riekkinen P., Smets P., Lowenthal A. European Stroke Prevention Study: Effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke. 23:1992;851-854.
31. Turney T., Garraway W.M., Whisnant J.P. The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke. 15:1984;790-794.
32. Tuszynski M.H., Petito C.K., Levy D.E. Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke. 20:1989;990-999.
33. Wolf, P.A., Kannel, W.B., Verter, J., 1983. Current status of risk factors for stroke. In: Barnett, H.J.M. (Ed.), Neurologic Clinics. Cerebrovascular Disease, vol. 1, no. 1. W.B. Saunders Co., Philadelphia, pp. 1317-1343.
34. Wolf P.A., D'Agostino R.B., Kannel W.B., Bonita R., Belanger A.J. Cigarette smoking as a risk factor for stroke. J. Am. Med. Assoc. 259:1988;1025-1029.